HUP0202736A3 - Substituted aromatic-ring compounds, process for producing the same, and pharmaceutical compositions containing them and use thereof - Google Patents

Substituted aromatic-ring compounds, process for producing the same, and pharmaceutical compositions containing them and use thereof

Info

Publication number
HUP0202736A3
HUP0202736A3 HU0202736A HUP0202736A HUP0202736A3 HU P0202736 A3 HUP0202736 A3 HU P0202736A3 HU 0202736 A HU0202736 A HU 0202736A HU P0202736 A HUP0202736 A HU P0202736A HU P0202736 A3 HUP0202736 A3 HU P0202736A3
Authority
HU
Hungary
Prior art keywords
producing
pharmaceutical compositions
same
compositions containing
substituted aromatic
Prior art date
Application number
HU0202736A
Other languages
English (en)
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of HUP0202736A2 publication Critical patent/HUP0202736A2/hu
Publication of HUP0202736A3 publication Critical patent/HUP0202736A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HU0202736A 1999-08-06 2000-08-03 Substituted aromatic-ring compounds, process for producing the same, and pharmaceutical compositions containing them and use thereof HUP0202736A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22424899 1999-08-06
PCT/JP2000/005197 WO2001010826A1 (en) 1999-08-06 2000-08-03 Substituted aromatic-ring compounds, process for producing the same, and use

Publications (2)

Publication Number Publication Date
HUP0202736A2 HUP0202736A2 (hu) 2003-01-28
HUP0202736A3 true HUP0202736A3 (en) 2005-05-30

Family

ID=16810814

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202736A HUP0202736A3 (en) 1999-08-06 2000-08-03 Substituted aromatic-ring compounds, process for producing the same, and pharmaceutical compositions containing them and use thereof

Country Status (12)

Country Link
US (2) US7078540B1 (hu)
EP (1) EP1209149B9 (hu)
KR (2) KR20070095416A (hu)
CN (1) CN1210257C (hu)
AT (1) ATE482930T1 (hu)
AU (1) AU6471200A (hu)
CA (1) CA2380990A1 (hu)
DE (1) DE60045033D1 (hu)
HU (1) HUP0202736A3 (hu)
NO (1) NO20020570L (hu)
PL (1) PL353635A1 (hu)
WO (1) WO2001010826A1 (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1210257C (zh) * 1999-08-06 2005-07-13 武田药品工业株式会社 取代的芳香环化合物及其制备方法和用途
KR20030005202A (ko) 2000-02-21 2003-01-17 다케다 야쿠힌 고교 가부시키가이샤 환상 화합물의 제조 방법
WO2002013816A1 (en) * 2000-08-10 2002-02-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition
CA2431206C (en) * 2000-12-08 2009-09-01 Takeda Chemical Industries, Ltd. Combination drugs containing anti-sepsis cycloalkene compound
US20060058288A1 (en) * 2002-04-08 2006-03-16 Masayuki Ii Severe sepsis preventive therapeutic agent
JP2006275022A (ja) * 2005-03-30 2006-10-12 Anest Iwata Corp 消音装置付きスクロール流体機械
TWI462745B (zh) * 2005-04-28 2014-12-01 Takeda Pharmaceutical 安定的乳化組成物
AU2006289921B2 (en) * 2005-09-14 2010-11-18 Daiichi Sankyo Company, Limited Substituted cycloalkene derivative
WO2007114296A1 (ja) 2006-03-30 2007-10-11 Hiroshima University スクリーニング方法
US20090062355A1 (en) 2006-04-20 2009-03-05 Takeda Pharmaceutical Company Limited Pharmaceutical Product
JPWO2007132825A1 (ja) * 2006-05-15 2009-09-24 武田薬品工業株式会社 医薬
US20090209585A1 (en) * 2006-07-07 2009-08-20 Takashi Ichikawa Cycloalkene derivatives, process for production of the derivatives, and use of the same
CN101776652B (zh) * 2010-01-11 2012-07-04 湘潭大学 由氮氧化合物生产的亚硝酰硫酸溶液中的亚硝酰硫酸、硫酸与三氧化硫含量的分析方法
NZ601635A (en) 2010-01-27 2013-06-28 Takeda Pharmaceutical Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent
US9364438B2 (en) 2012-09-26 2016-06-14 Takeda Pharmaceutical Company Limited Process for producing solid particles
US9611244B2 (en) 2015-05-08 2017-04-04 Takeda Pharmaceutical Company Limited Cyclic compounds
GB201612652D0 (en) * 2016-07-21 2016-09-07 Takeda Pharmaceuticals Co Novel compound
EP3511320A4 (en) * 2016-09-09 2020-04-15 Takeda Pharmaceutical Company Limited CYCLIC CONNECTION

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378703A (en) * 1990-04-09 1995-01-03 Alcon Laboratories, Inc. Sulfonamides useful as carbonic anhydrase inhibitors
EP1048657A1 (en) * 1995-04-04 2000-11-02 Texas Biotechnology Corporation Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
RU2214398C2 (ru) 1998-03-09 2003-10-20 Такеда Кемикал Индастриз, Лтд. Производное циклоалкена, способ его получения (варианты), фармацевтическая композиция, способ ингибирования, способ профилактики или лечения
CN1326452A (zh) * 1998-10-06 2001-12-12 出光兴产株式会社 三酮衍生物与除草剂
CN1210257C (zh) * 1999-08-06 2005-07-13 武田药品工业株式会社 取代的芳香环化合物及其制备方法和用途
US20030100580A1 (en) * 2002-06-13 2003-05-29 Dashyant Dhanak Urotensin-II receptor antagonists

Also Published As

Publication number Publication date
CN1374946A (zh) 2002-10-16
KR20070095416A (ko) 2007-09-28
EP1209149B9 (en) 2011-08-31
US7417059B2 (en) 2008-08-26
KR20020032548A (ko) 2002-05-03
KR100778256B1 (ko) 2007-11-27
EP1209149A4 (en) 2005-04-20
CN1210257C (zh) 2005-07-13
WO2001010826A1 (en) 2001-02-15
PL353635A1 (en) 2003-12-01
NO20020570L (no) 2002-03-22
DE60045033D1 (de) 2010-11-11
CA2380990A1 (en) 2001-02-15
AU6471200A (en) 2001-03-05
ATE482930T1 (de) 2010-10-15
EP1209149B1 (en) 2010-09-29
HUP0202736A2 (hu) 2003-01-28
US7078540B1 (en) 2006-07-18
US20050176783A1 (en) 2005-08-11
NO20020570D0 (no) 2002-02-05
EP1209149A1 (en) 2002-05-29

Similar Documents

Publication Publication Date Title
HUP0203766A3 (en) 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof and pharmaceutical compositions containing them
HUP0000748A2 (en) 4-phenyl-piridine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0203542A3 (en) 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
HUP9900120A3 (en) Benzosulfone derivatives, process for producing them and pharmaceutical compositions containing them
HUP0002050A3 (en) Substituted imidazole compounds, process for producing them, pharmaceutical compositions containing them and their use
HUP0203902A3 (en) Substituted oxazolidinones, process for their preparation and pharmaceutical compositions containing them and their use
IL135920A0 (en) 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor
HUP0202810A3 (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands, process for their preparation and pharmaceutical compositions containing them
HUP0001508A3 (en) 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
HUP0201122A3 (en) Pyrimidinone compounds, process for their preparation and pharmaceutical compositions containing them
HUP0105108A3 (en) Amide compounds, process for their preparation and pharmaceutical compositions containing them
HUP0102732A3 (en) Substituted amids, their use for producing pharmaceutical compositions and pharmaceutical compositions containing them
HUP0202736A3 (en) Substituted aromatic-ring compounds, process for producing the same, and pharmaceutical compositions containing them and use thereof
HUP0102215A3 (en) Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation
HUP0202075A3 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203496A3 (en) Novel cyclopropane derivatives, pharmaceutical compositions containing them and method for the production thereof
HUP0201402A3 (en) Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
HUP0105479A3 (en) Betha-alanine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0001093A3 (en) Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation
HUP0201785A3 (en) Dihydrobenzodiazepins, process for producing them, their use and pharmaceutical compositions containing them
EP1539718A4 (en) 1,2,4-TRIAZOL DERIVATIVE, METHOD FOR THE PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
HUP0103316A3 (en) 2-ureido-pyrimidone derivatives, method for producing them, pharmaceutical compositions containing them and their use
HUP0101482A3 (en) Piperidinyl and n-amidinopiperidinyl derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing the same
HUP0302429A3 (en) 4-amino-quinazolines, process for producing them, pharmaceutical compositions containing them and their use
HUP9602763A3 (en) 3-phenyl isoxazole derivatives, process for producing them and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees